| UniProt ID | TRI35_HUMAN | |
|---|---|---|
| UniProt AC | Q9UPQ4 | |
| Protein Name | Tripartite motif-containing protein 35 | |
| Gene Name | TRIM35 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 493 | |
| Subcellular Localization | Cytoplasm . Nucleus. Found predominantly in cytoplasm with a granular distribution. Found in punctuate nuclear bodies (By similarity).. | |
| Protein Description | Reduces FGFR1-dependent tyrosine phosphorylation of PKM, inhibiting PKM-dependent lactate production, glucose metabolism, and cell growth. [PubMed: 25263439 Involved in the cell death mechanism (By similarity] | |
| Protein Sequence | MERSPDVSPGPSRSFKEELLCAVCYDPFRDAVTLRCGHNFCRGCVSRCWEVQVSPTCPVCKDRASPADLRTNHTLNNLVEKLLREEAEGARWTSYRFSRVCRLHRGQLSLFCLEDKELLCCSCQADPRHQGHRVQPVKDTAHDFRAKCRNMEHALREKAKAFWAMRRSYEAIAKHNQVEAAWLEGRIRQEFDKLREFLRVEEQAILDAMAEETRQKQLLADEKMKQLTEETEVLAHEIERLQMEMKEDDVSFLMKHKSRKRRLFCTMEPEPVQPGMLIDVCKYLGSLQYRVWKKMLASVESVPFSFDPNTAAGWLSVSDDLTSVTNHGYRVQVENPERFSSAPCLLGSRVFSQGSHAWEVALGGLQSWRVGVVRVRQDSGAEGHSHSCYHDTRSGFWYVCRTQGVEGDHCVTSDPATSPLVLAIPRRLRVELECEEGELSFYDAERHCHLYTFHARFGEVRPYFYLGGARGAGPPEPLRICPLHISVKEELDG | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MERSPDVS -------CCCCCCCC | 9.72 | 21406692 | |
| 4 | Phosphorylation | ----MERSPDVSPGP ----CCCCCCCCCCC | 16.49 | 29255136 | |
| 8 | Phosphorylation | MERSPDVSPGPSRSF CCCCCCCCCCCCCCH | 31.36 | 29255136 | |
| 12 | Phosphorylation | PDVSPGPSRSFKEEL CCCCCCCCCCHHHHH | 46.61 | 29255136 | |
| 14 | Phosphorylation | VSPGPSRSFKEELLC CCCCCCCCHHHHHHH | 45.03 | 21955146 | |
| 61 | Ubiquitination | SPTCPVCKDRASPAD CCCCCCCCCCCCHHH | 50.94 | - | |
| 65 | Phosphorylation | PVCKDRASPADLRTN CCCCCCCCHHHHHHH | 22.86 | 30266825 | |
| 71 | Phosphorylation | ASPADLRTNHTLNNL CCHHHHHHHHHHHHH | 38.35 | 24076635 | |
| 74 | Phosphorylation | ADLRTNHTLNNLVEK HHHHHHHHHHHHHHH | 33.00 | 24076635 | |
| 138 | Trimethylation | GHRVQPVKDTAHDFR CCCCCCCCCCHHHHH | 56.92 | - | |
| 138 | Ubiquitination | GHRVQPVKDTAHDFR CCCCCCCCCCHHHHH | 56.92 | - | |
| 138 | Methylation | GHRVQPVKDTAHDFR CCCCCCCCCCHHHHH | 56.92 | 23644510 | |
| 160 | Ubiquitination | HALREKAKAFWAMRR HHHHHHHHHHHHHHH | 56.00 | - | |
| 168 | Phosphorylation | AFWAMRRSYEAIAKH HHHHHHHHHHHHHHH | 19.57 | 22817900 | |
| 169 | Phosphorylation | FWAMRRSYEAIAKHN HHHHHHHHHHHHHHC | 13.94 | 22817900 | |
| 174 | Ubiquitination | RSYEAIAKHNQVEAA HHHHHHHHHCHHHHH | 36.65 | - | |
| 174 (in isoform 2) | Phosphorylation | - | 36.65 | 25159151 | |
| 193 | Ubiquitination | RIRQEFDKLREFLRV HHHHHHHHHHHHHHH | 55.56 | - | |
| 216 | Ubiquitination | MAEETRQKQLLADEK HHHHHHHHHHHCHHH | 39.35 | - | |
| 223 | Ubiquitination | KQLLADEKMKQLTEE HHHHCHHHHHHHHHH | 52.52 | - | |
| 225 | Ubiquitination | LLADEKMKQLTEETE HHCHHHHHHHHHHHH | 53.90 | - | |
| 246 | Ubiquitination | ERLQMEMKEDDVSFL HHHHHHCCCCHHHHH | 44.69 | - | |
| 255 | Ubiquitination | DDVSFLMKHKSRKRR CHHHHHHHCCCCCCE | 50.45 | - | |
| 257 | Ubiquitination | VSFLMKHKSRKRRLF HHHHHHCCCCCCEEE | 46.57 | - | |
| 257 | Acetylation | VSFLMKHKSRKRRLF HHHHHHCCCCCCEEE | 46.57 | 7407745 | |
| 258 | O-linked_Glycosylation | SFLMKHKSRKRRLFC HHHHHCCCCCCEEEE | 42.63 | 30379171 | |
| 260 | Acetylation | LMKHKSRKRRLFCTM HHHCCCCCCEEEEEC | 49.30 | 7407755 | |
| 379 | Phosphorylation | VVRVRQDSGAEGHSH EEEEECCCCCCCCCC | 31.40 | 24043423 | |
| 385 | Phosphorylation | DSGAEGHSHSCYHDT CCCCCCCCCCCEEEC | 28.14 | 24043423 | |
| 387 | Phosphorylation | GAEGHSHSCYHDTRS CCCCCCCCCEEECCC | 21.27 | 24043423 | |
| 389 | Phosphorylation | EGHSHSCYHDTRSGF CCCCCCCEEECCCCE | 13.02 | 24043423 | |
| 392 | Phosphorylation | SHSCYHDTRSGFWYV CCCCEEECCCCEEEE | 17.27 | 24043423 | |
| 417 | Phosphorylation | CVTSDPATSPLVLAI EECCCCCCCCEEEEE | 35.94 | 23312004 | |
| 418 | Phosphorylation | VTSDPATSPLVLAIP ECCCCCCCCEEEEEE | 20.53 | 23312004 | |
| 488 | Ubiquitination | CPLHISVKEELDG-- CCEEEEEEHHHCC-- | 38.39 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TRI35_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TRI35_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TRI35_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TRIM5_HUMAN | TRIM5 | physical | 16775307 | |
| KPYM_HUMAN | PKM | physical | 25263439 | |
| AKTIP_HUMAN | AKTIP | physical | 28514442 | |
| 2ABD_HUMAN | PPP2R2D | physical | 28514442 | |
| OTUD5_HUMAN | OTUD5 | physical | 28514442 | |
| KDM5C_HUMAN | KDM5C | physical | 28514442 | |
| KLH11_HUMAN | KLHL11 | physical | 28514442 | |
| WDR20_HUMAN | WDR20 | physical | 28514442 | |
| LIMD1_HUMAN | LIMD1 | physical | 28514442 | |
| 2AAB_HUMAN | PPP2R1B | physical | 28514442 | |
| MYO1F_HUMAN | MYO1F | physical | 28514442 | |
| MTA2_HUMAN | MTA2 | physical | 28514442 | |
| HSP7E_HUMAN | HSPA14 | physical | 28514442 | |
| LIMK2_HUMAN | LIMK2 | physical | 28514442 | |
| ZMYM2_HUMAN | ZMYM2 | physical | 28514442 | |
| KIF1A_HUMAN | KIF1A | physical | 28514442 | |
| PIAS1_HUMAN | PIAS1 | physical | 28514442 | |
| MKS1_HUMAN | MKS1 | physical | 28514442 | |
| UBP7_HUMAN | USP7 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65, AND MASSSPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4 AND SER-8, AND MASSSPECTROMETRY. | |